Wintest
6721
Osaka Yuka Industry
4124
D. Western Therapeutics Institute
4576
Asiro
7378
Hamee
3134
(FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | (Q1)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | -17.89%3.85B | 37.82%1.31B | -72.71%530M | -8.38%776M | 29.93%1.23B | 59.20%4.69B | -22.35%952M | 107.04%1.94B | -12.77%847M | 602.12%949M |
Net profit before non-cash adjustment | -17.51%2.66B | -9.94%707M | -37.68%736M | 25.45%557M | -18.99%657M | -2.39%3.22B | -0.76%785M | 30.64%1.18B | -41.73%444M | -3.80%811M |
Total adjustment of non-cash items | 61.55%1.17B | 11.51%155M | 437.00%337M | -34.62%389M | 222.47%287M | -9.63%723M | -32.20%139M | -143.86%-100M | 148.95%595M | -30.47%89M |
-Depreciation and amortization | 23.48%957M | 37.14%288M | 30.46%257M | 11.05%211M | 12.92%201M | 5.01%775M | 2.94%210M | 2.07%197M | 9.20%190M | 6.59%178M |
-Disposal profit | 138.14%74M | 16.67%7M | 119.60%49M | -97.87%1M | 466.67%17M | -473.08%-194M | --6M | -571.70%-250M | 4,800.00%47M | --3M |
-Other non-cash items | -3.52%137M | -81.82%-140M | 165.96%31M | -50.56%177M | 175.00%69M | 1,477.78%142M | ---77M | -161.11%-47M | 442.42%358M | -135.90%-92M |
Changes in working capital | -96.51%26M | 1,507.14%450M | -162.69%-541M | 13.85%-168M | 481.63%285M | 164.45%745M | -87.67%28M | 547.15%863M | -596.43%-195M | 104.22%49M |
-Change in receivables | -135.19%-291M | 2.83%508M | -344.81%-590M | -805.88%-240M | -46.55%31M | 173.25%827M | -5.18%494M | 126.63%241M | -69.91%34M | 106.76%58M |
-Change in inventory | 207.41%29M | ---- | ---- | ---- | ---- | -2,800.00%-27M | ---- | ---- | ---- | ---- |
-Change in payables | 393.02%252M | 73.83%-123M | -92.12%49M | 131.44%72M | 2,922.22%254M | -152.94%-86M | -56.15%-470M | -12.64%622M | -62.41%-229M | 97.04%-9M |
-Provision for loans, leases and other losses | 16.13%36M | ---- | ---- | ---- | ---- | 416.67%31M | ---- | ---- | ---- | ---- |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | -125.71%-79M | -111.11%-19M | -110.00%-21M | -111.11%-19M | -185.71%-20M | -12.90%-35M | -50.00%-9M | -11.11%-10M | -28.57%-9M | 22.22%-7M |
Interest received (cash flow from operating activities) | -63.16%7M | 1M | -80.00%2M | -50.00%1M | -57.14%3M | 5.56%19M | 0 | 100.00%10M | 0.00%2M | -22.22%7M |
Tax refund paid | -8.92%-965M | -13M | 0.84%-473M | 0 | -17.11%-479M | 30.35%-886M | 0 | 11.17%-477M | 0 | 43.97%-409M |
Other operating cash inflow (outflow) | 99.56%-1M | 94.74%-1M | 100.53%1M | 0 | 90.91%-1M | -2,172.73%-228M | -850.00%-19M | -1,561.54%-190M | -900.00%-8M | -1,000.00%-11M |
Operating cash flow | -20.98%2.81B | 38.53%1.28B | -96.94%39M | -8.89%758M | 39.13%736M | 112.92%3.56B | -23.89%924M | 210.98%1.28B | -14.05%832M | 157.50%529M |
Investing cash flow | ||||||||||
Net PPE purchase and sale | -51.88%-5.25B | -189.97%-2.26B | 302.42%419M | 96.85%-62M | -566.00%-3.35B | -181.66%-3.46B | -50.19%-778M | 41.03%-207M | -706.56%-1.97B | -341.23%-503M |
Net intangibles purchase and sale | -461.19%-376M | -312.50%-66M | -663.33%-229M | -142.86%-17M | -357.14%-64M | 48.06%-67M | 44.83%-16M | 30.23%-30M | 80.56%-7M | 33.33%-14M |
Net investment product transactions | -87.67%55M | --0 | --0 | ---- | ---- | 869.57%446M | --0 | --445M | ---- | ---- |
Net changes in other investments | 139.51%32M | -14.29%-16M | 306.67%62M | 113.33%2M | 27.27%-16M | -345.45%-81M | -125.45%-14M | -400.00%-30M | -1,600.00%-15M | -29.41%-22M |
Investing cash flow | -75.36%-5.54B | -189.36%-2.34B | 41.57%252M | 98.89%-22M | -536.36%-3.43B | -147.30%-3.16B | -62.58%-808M | 151.00%178M | -612.90%-1.99B | -254.61%-539M |
Financing cash flow | ||||||||||
Net issuance payments of debt | 349.06%3.83B | 34.13%-137M | 19.64%-266M | -118.25%-258M | 19,608.70%4.49B | 12,071.43%852M | -166.03%-208M | -873.53%-331M | 382.80%1.41B | -110.18%-23M |
Cash dividends paid | -8.01%-701M | --0 | 0.00%-351M | --0 | -17.45%-350M | -8.89%-649M | --0 | -17.79%-351M | --0 | 0.00%-298M |
Net other fund-raising expenses | -135.29%-40M | -42.86%-10M | -350.00%-9M | -150.00%-10M | -175.00%-11M | 78.75%-17M | 22.22%-7M | 90.00%-2M | 84.62%-4M | 84.00%-4M |
Financing cash flow | 1,558.60%3.09B | 31.63%-147M | 8.48%-626M | -119.01%-268M | 1,369.54%4.13B | 127.80%186M | -170.26%-215M | -94.32%-684M | 368.06%1.41B | -235.05%-325M |
Net cash flow | ||||||||||
Beginning cash position | 12.23%5.4B | 26.68%6.96B | 54.35%7.3B | 52.71%6.83B | 12.23%5.4B | -5.39%4.81B | 45.22%5.5B | 16.00%4.73B | 14.31%4.47B | -5.39%4.81B |
Current changes in cash | -38.78%360M | -1,117.17%-1.21B | -143.56%-335M | 84.98%468M | 527.46%1.43B | 314.60%588M | -109.68%-99M | 364.26%769M | 55.21%253M | 71.34%-335M |
Cash adjustments other than cash changes | ---- | ---- | ---- | ---- | 200.00%1M | ---- | ---- | ---- | --2M | 0.00%-1M |
End cash Position | 6.67%5.76B | 6.67%5.76B | 26.68%6.96B | 54.35%7.3B | 52.71%6.83B | 12.23%5.4B | 12.23%5.4B | 45.22%5.5B | 16.00%4.73B | 14.31%4.47B |
Free cash flow | -3,253.57%-2.82B | -934.40%-1.04B | -77.99%228M | 153.86%676M | -26,880.00%-2.68B | -131.00%-84M | -81.15%125M | 5,280.00%1.04B | -283.21%-1.26B | 100.95%10M |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |